Related Experiment Video

Updated: May 5, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

7.1K

S6K1 negatively regulates TAK1 activity in the toll-like receptor signaling pathway

So Yong Kim1, Kyung-Hwa Baik, Kwan-Hyuck Baek

  • 1Department of Molecular Cell Biology and Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.

Molecular and Cellular Biology
|November 27, 2013
PubMed

Insights

Ribosomal S6 kinase 1 (S6K1) inhibits Toll-like receptor (TLR) signaling by blocking Transforming growth factor β-activated kinase 1 (TAK1) activity. This finding clarifies immune regulation and its link to type 2 diabetes.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Transforming growth factor β (TGF-β)-activated kinase 1 (TAK1) is crucial for inflammatory and Toll-like receptor (TLR) signaling pathways.
  • The precise regulation of TAK1 activity across different tissues and stimuli is not fully understood.
  • Understanding TAK1 regulation is vital for deciphering immune responses and associated diseases.

Purpose of the Study:

  • To investigate the role of ribosomal S6 kinase 1 (S6K1) in regulating TLR-mediated signaling.
  • To elucidate the molecular mechanism by which S6K1 influences TAK1 activity.
  • To explore the implications of S6K1-TAK1 interaction in inflammatory diseases, including type 2 diabetes.

Main Methods:

  • Utilized cell overexpression and knockdown models to assess S6K1's impact on TLR signaling.
  • Employed knockout mice (S6K1-/-) to study in vivo effects of S6K1 deficiency on inflammatory responses and survival.
  • Investigated the interaction between S6K1, TAK1, and TAB1 using biochemical assays to determine the mechanism of inhibition.

Main Results:

  • S6K1 overexpression reduced NF-κB and AP-1 activation induced by TLR2/TLR4 stimulation.
  • S6K1 deficiency led to enhanced inflammatory cytokine production and decreased survival in response to LPS challenge.
  • S6K1 directly inhibits TAK1 kinase activity by disrupting the TAK1-TAB1 interaction, thereby dampening TLR signaling.

Conclusions:

  • S6K1 acts as a negative regulator of TLR-mediated inflammatory signaling by inhibiting TAK1 activity.
  • The findings reveal a novel mechanism of immune response modulation involving S6K1 and TAK1.
  • This research provides insights into the molecular pathogenesis of impaired immune responses in type 2 diabetes, linking S6K1's role in insulin resistance and TLR signaling.

More Related Videos

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation09:04

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation

Published on: September 7, 2010

11.0K
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

11.9K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.7K